Pfizer
PFE
PFE
2,036 hedge funds and large institutions have $151B invested in Pfizer in 2017 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 820 increasing their positions, 900 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
1.15% more ownership
Funds ownership: 73.81% → 74.96% (+1.2%)
0% less funds holding
Funds holding: 2,045 → 2,036 (-9)
9% less repeat investments, than reductions
Existing positions increased: 820 | Existing positions reduced: 900
Holders
2,036
Holding in Top 10
175
Calls
$1.45B
Puts
$1.23B
Top Buyers
| 1 | +$475M | |
| 2 | +$243M | |
| 3 | +$228M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$222M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$222M |
Top Sellers
| 1 | -$262M | |
| 2 | -$234M | |
| 3 | -$206M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$164M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$121M |